Walmart is selling a 'reliable' $590 portable generator for $299, and shoppers say it has 'exceptional power'
No power? No problem. For avid campers or those who are nervous about electrical outages, a portable generator should be readily available to you at all times.
That's why we were excited to find the Efurden 2500-Watt Portable Generator on sale at Walmart during the retailer's Super Savings Week. You can save 49% on this must-have emergency device that will give you added peace of mind.
Weighing less than 40 pounds, this portable generator is lighter and more compact than other options on the market. It measures 18 inches long, 11 inches wide, and 17.5 inches high, and includes a sturdy handle that allows you to easily take it with you from place to place. The generator features two 120V AC outlets, one USB socket, one 12V DC socket, and one type C socket that can power anything from laptops and smartphones to televisions and small appliances.
"Exceptional power in a lightweight package," said one shopper. "Quite quiet, lightweight, portable, and simple to use."Another reviewer wrote, "It's an all-around fantastic backup that's easy to use and reliable. Despite being heavily utilized and subjected to damage throughout a home remodeling, it continues to function flawlessly and never fails."
With a pull cord start, the generator features a 1.1 gallon gasoline tank that supports up to 9.5 hours at 25% load, six hours at 50%, and 3.5 hours at full capacity. For even more power, you can connect two inverters together to keep your electronics running for longer. One important safety feature of this device is the CO alert that automatically shuts down the generator if a high concentration is detected.
A third shopper said, "This small device is incredibly quiet, lightweight, portable, and ideal for camping or when electricity is required."
Walmart's Super Savings Week is almost over, so be sure to add this $299 portable generator to your cart to cash in on all the savings.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
10 hours ago
- Gizmodo
Walmart Restocked Texas Instruments Graphing Calculator at Record Low for Back-to-School
Thankfully, we don't live in a time when solving one math problem could take all day. Of course, that might have been satisfying in its own way, but considering how we have more resources now, it just makes more sense to use tools that save time and help you learn more effectively. That's exactly what the Texas Instruments TI-84 Plus graphing calculator does, and right now, you can grab it for just $87, which is $52 off the regular price on Walmart. Given how long you'll use it and how much easier it can make your studies, that's one solid deal, but most likely a limited-time one. See at Walmart It doesn't just crunch and punch numbers. You get more than a dozen preloaded apps that can cover subjects like algebra, geometry, statistics, biology, physics, and even finance. We're talking apps like Cabri Jr for interactive geometry and Inequality Graphing for comparing multiple inequalities at once. And since it's a graphing calculator, you won't be limited to plain, boring numbers. You can work with detailed graphs that make even complicated concepts easy to understand. There's a MathPrint feature that lets you enter fractions and equations just as they appear in your books or typed by professors on the board – great for reducing any chances of errors. Best of all, it's approved for major exams like the SAT, ACT, AP, and IB, so you can bring it with you on exam day. The screen displays 10 digits across and up to eight lines at a time, so unless you're working on the Boolean Pythagorean Triples problem or trying to give Einstein a run for the theory of relativity, you'll have more than enough space to see what you're working on without having to scroll down. It also includes a USB cable that lets you connect it to your laptop or PC for updates and data sharing. This is great for transferring your collected data and even creating a backup of your work. All things considered, the calculator is great for students at just about any level, from middle school through college. It lets you understand complex topics and solve a range of problems across different subjects. At $87, with $52 off the regular price at Walmart, it's a great opportunity to snag it for less. Just note that it might not last too long, so we recommend grabbing it at a discount while you can. See at Walmart
Bloomberg
10 hours ago
- Bloomberg
Stock Movers: Bullish, CoreWeave, Cisco
On this edition of Stock Movers: - Bullish (BLSH) shares jumped 84% from the IPO price after the digital-asset exchange operator and owner of media outlet CoinDesk raised $1.1 billion in an initial public offering. Shares of the Cayman Islands-based company closed at $68 each on Wednesday in New York, nearly doubling its IPO price of $37 apiece. The offering was upsized earlier in the week to 30 million shares, and the price range was increased. The trading gives Bullish a market value of $9.9 billion based on the outstanding shares listed in its filing. The IPO ended more than 20 times oversubscribed, with about a third of orders receiving no shares at all, people familiar with the matter have said. - Walmart (WMT), Instacart (CART), and Kroger (KR) shares fell after Inc. announced plans to offer same-day grocery delivery in 2,300 cities by the end of the year. Customers will be able to order perishable items such as produce, dairy, meat, seafood and baked goods, alongside frozen foods and household items, the company said in a statement on Wednesday. Same-day grocery delivery is free for Amazon Prime subscribers on orders over $25 in most cities, it said. For non-members, the service carries a $12.99 fee, regardless of order size. - CoreWeave (CRWV) shares tumbled after the cloud-computing provider reported a wider quarterly loss and gave a disappointing earnings outlook, raising concerns about its rapid AI data center expansion pressuring profit margins. Third-quarter operating income will be $160 million to $190 million, the company said Tuesday, underwhelming investors looking to justify a near-quadrupling of its share price since its March debut. Costs are surging, and CoreWeave posted a loss of $131 million for the June quarter — more than 20 times bigger than the loss a year earlier. - Cisco Systems (CSCO) shares fell after the company gave a lukewarm forecast for the current fiscal year, disappointing investors who hoped for a boost from massive AI data center projects. Sales will be between $59 billion and $60 billion in the fiscal year that runs through July 2026, the company said in a statement Wednesday. At the midpoint, that's roughly in line with the average Wall Street estimate of $59.5 billion, according to data compiled by Bloomberg. Some analysts, though, we're looking for more than $61 billion.
Yahoo
11 hours ago
- Yahoo
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
BOULDER, CO / / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the launch of its HOCl-based diaper rash product for infants and children into large retailers in the United States. The antimicrobial hydrogel is being marketed and sold through Sonoma's U.S.-based distribution partner. The diaper rash product is currently carried in 3,600 Walmart stores, and certain large grocery chains. "We are excited to see our strategy of expanding into the over-the-counter space begin to take hold with our first U.S. product targeted to consumers launched into large scale retail channels," said Amy Trombly, CEO of Sonoma. "We are also pleased about the increased availability of our Microcyn technology for consumers who seek safe and effective solutions for diaper rash and other skin irritations." About Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma's products are sold either directly or via partners in 55 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at For partnership opportunities, please contact busdev@ Forward-Looking Statements Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the "company"). These forward-looking statements are identified by the use of words such as "continue," "develop," "anticipate," "expect" and "expand," among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company's business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company's patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, the ability to meet a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law. Sonoma Pharmaceuticals™ and Microcyn® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners. Media and Investor Contact: Sonoma Pharmaceuticals, Website: us on LinkedIn: us on Instagram: us on Facebook: SOURCE: Sonoma Pharmaceuticals, Inc. View the original press release on ACCESS Newswire
